Sensitive skin
(UMLS:C4228089)
- UMLS ID:
- C4228089
- MeSH ID:
- N/A
Synonym(s)
1.
Sensitive skin
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lamotrigine | FAERS: 5 | US FAERS | |
| 2 | pazopanib | FAERS: 3 | US FAERS | |
| 3 | Cetirizine | FAERS: 2 | US FAERS | |
| 4 | Exenatide | FAERS: 2 | US FAERS | |
| 5 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 6 | Insulin Glargine | FAERS: 2 | US FAERS | |
| 7 | Lenalidomide | FAERS: 2 | US FAERS | |
| 8 | pomalidomide | FAERS: 2 | US FAERS | |
| 9 | teriflunomide | FAERS: 2 | US FAERS | |
| 10 | AMG-416 | FAERS: 1 | US FAERS | |
| 11 | ARRY-470 | FAERS: 1 | US FAERS | |
| 12 | Dasatinib | FAERS: 1 | US FAERS | |
| 13 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 14 | Estrogens, Conjugated (USP) | FAERS: 1 | US FAERS | |
| 15 | Fluticasone | FAERS: 1 | US FAERS | |
| 16 | Furosemide | FAERS: 1 | US FAERS | |
| 17 | Lisdexamfetamine Dimesylate | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Loteprednol Etabonate | FAERS: 1 | US FAERS | |
| 19 | Methylprednisolone Acetate | FAERS: 1 | US FAERS | |
| 20 | Naltrexone | FAERS: 1 | US FAERS | |
| 21 | Norgestrel | FAERS: 1 | US FAERS | |
| 22 | Prednisolone | FAERS: 1 | US FAERS | |
| 23 | Pregabalin | FAERS: 1 | US FAERS | |
| 24 | Risperidone | FAERS: 1 | US FAERS | |
| 25 | Vortioxetine hydrobromide | FAERS: 1 | US FAERS | |
| 26 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 27 | apremilast | FAERS: 1 | US FAERS | |
| 28 | etonogestrel | FAERS: 1 | US FAERS | |
| 29 | palbociclib | FAERS: 1 | US FAERS | |
| 30 | rucaparib | FAERS: 1 | US FAERS | |
| 31 | selexipag | FAERS: 1 | US FAERS | |
| 32 | Docetaxel | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120266
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.